Save time and get answers to complex questions with AI chat
Alogliptin benz cost?Testosterone enanthate expiration?Guselkumab brand name?The expiration date of the key patent for guselkumab?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for Tecvayli
Tecvayli is teclistamab, a BCMA-directed bispecific antibody for multiple myeloma developed by Janssen/Genmab. I don’t have the exact 2023 net sales figure memorized. Would you like me to fetch the precise number (global calendar-year net sales, and in USD or EUR) from Genmab/Janssen results? If you have a preferred source (Genmab annual report, quarterly results, or press release), I can pull that specific figure.
Other Questions About Tecvayli :